Psychological wellbeing and physical activity in children and adolescents with inflammatory bowel disease compared to healthy controls

Laura Mählmann, Markus Gerber, Raoul I Furlano, Corinne Legeret, Nadeem Kalak, Edith Holsboer-Trachsler, Serge Brand, Laura Mählmann, Markus Gerber, Raoul I Furlano, Corinne Legeret, Nadeem Kalak, Edith Holsboer-Trachsler, Serge Brand

Abstract

Background: Children and adolescents with inflammatory bowel disease (IBD) report impairments in daily activities, social interactions and coping. Findings regarding psychological functioning are inconsistent, while limited information is available on objectively assessed physical activity (PA). The aims of the present study were therefore to compare anthropometric dimensions, blood values, psychological functioning and PA of children and adolescents with IBD with healthy controls.

Methods: Forty-seven children and adolescents took part in the study. Of these, 23 were diagnosed with IBD (mean age: 13.88 years, 44% females). The IBD group was divided into a medically well adjusted "remission-group" (n = 14; IBD-RE) and a group with an "active state" of disease (n = 8; IBD-AD). Healthy controls (n = 24; HC) were age- and gender-matched. Participants' anthropometric data, blood values and objective PA were assessed. Further, participants completed questionnaires covering socio-demographic data and psychological functioning.

Results: Participants with IBD-AD showed higher erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) values, haemoglobin, and leukocyte values. IBD-AD had poorer psychological functioning and lower PA (average steps per day) compared to IBD-RE and HC. No mean differences were found between IBD-RE and HC.

Conclusions: The pattern of results suggests that effective medical treatment of IBD in children and adolescents is associated with favorable physiological parameters, psychological dimensions and PA. Psychological counselling of children and adolescents in an active state of IBD seem to be advised in addition to standard treatment schedules.

Trial registration: NCT NCT02264275 ; Registered 8 October 2014.

Keywords: Anthropometric dimensions; Blood values; Healthy controls; Inflammatory bowel diseases; Pediatrics; Physical activity; Psychological wellbeing.

Conflict of interest statement

Ethics approval and consent to participate

The present study was approved by the local ethical committee (Ethikkommission Nordwest- und Zentralschweiz (EKNZ): 2014:220), and was also conducted in accordance to the ethical principles laid down in Declaration of Helsinki (Trial registration number: NCT02264275). Voluntary participation was encouraged and informed consent to participate in the study was obtained from each patient. All participants and their legal guardian had to consent the study participation in written format.

Patient records or information was anonymized and de-identified prior to analysis.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

    1. Levine A, de Bie CI, Turner D, et al. Atypical disease phenotypes in pediatric ulcerative colitis: 5-year analyses of the EUROKIDS registry. Inflamm Bowel Dis. 2013;19:370–7.
    1. Lemberg DA, Day AS. Crohn disease and ulcerative colitis in children: an update for 2014. J Paediatr Child Health. 2015;51:266–270. doi: 10.1111/jpc.12685.
    1. Loddo I, Romano C. Inflammatory bowel disease: genetics, epigenetics, and pathogenesis. Front Immunol. 2015;6 Available from: . Cited 21 Mar 2016
    1. Braegger CP, Ballabeni P, Rogler D, Vavricka SR, Friedt M, Pittet V, et al. Epidemiology of inflammatory bowel disease: is there a shift towards onset at a younger age? J Pediatr Gastroenterol Nutr. 2011;53:141–144. doi: 10.1097/MPG.0b013e318218be35.
    1. Pappa H, Thayu M, Sylvester F, Leonard M, Zemel B, Gordon C. Skeletal health of children and adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011;53:11–25. doi: 10.1097/MPG.0b013e31821988a3.
    1. Rosen MJ, Dhawan A, Saeed SA. Inflammatory bowel disease in children and adolescents. JAMA Pediatr. 2015;169:1053. doi: 10.1001/jamapediatrics.2015.1982.
    1. Engstrom I. Mental-health and psychological functioning in children and adolescents with inflammatory bowel-disease: a comparison with children having other chronic illnesses and with healthy-children. J Child Psychol Psychiatry. 1992;3:563–582. doi: 10.1111/j.1469-7610.1992.tb00891.x.
    1. Ross SC, Strachan J, Russell RK, Wilson SL. Psychosocial functioning and health related quality of life in paediatric inflammatory bowel disease: a systematic review. J Pediatr Gastroenterol Nutr. 2011;53:480.
    1. Vaisto T, Aronen ET, Simola P, Ashorn M, Kolho KL. Psychosocial symptoms and competence among adolescents with inflammatory bowel disease and their peers. Inflamm Bowel Dis. 2010;1:27–35. doi: 10.1002/ibd.21002.
    1. Rabizadeh S, Dubinsky M. Update in pediatric inflammatory bowel disease. Rheum Dis Clin N Am. 2013;39:789–799. doi: 10.1016/j.rdc.2013.03.010.
    1. Mikocka-Walus A, Knowles SR, Keefer L, Graff L. Controversies revisited: a systematic review of the comorbidity of depression and anxiety with inflammatory bowel diseases. Inflamm Bowel Dis. 2016;22:752–762. doi: 10.1097/MIB.0000000000000620.
    1. Spekhorst LM, Hummel TZ, Benninga MA, van Rheenen PF, Kindermann A. Adherence to oral maintenance treatment in adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2016;62:264–270. doi: 10.1097/MPG.0000000000000924.
    1. Ploeger H, Obeid J, Nguyen T, Takken T, Issenman R, de Greef M, et al. Exercise and inflammation in pediatric Crohn’s disease. Int J Sports Med. 2012;33:671–679. doi: 10.1055/s-0032-1304323.
    1. Werkstetter KJ, Ullrich J, Schatz SB, Prell C, Koletzko B, Koletzko S. Lean body mass, physical activity and quality of life in paediatric patients with inflammatory bowel disease and in healthy controls. J Crohns Colitis. 2012;6:665–673. doi: 10.1016/j.crohns.2011.11.017.
    1. Loprinzi PD, Cardinal BJ. Association between objectively-measured physical activity and sleep, NHANES 2005–2006. Ment. Health and Phys Act. 2011;4:65–69. doi: 10.1016/j.mhpa.2011.08.001.
    1. Gerber M, Lindwall M, Lindegård A, Börjesson M, Jonsdottir IH. Cardiorespiratory fitness protects against stress-related symptoms of burnout and depression. Patient Educ Couns. 2013;93:146–152. doi: 10.1016/j.pec.2013.03.021.
    1. Hummel TZ, Tak E, Maurice-Stam H, Benninga MA, Kindermann A, Grootenhuis MA. Psychosocial developmental trajectory of adolescents with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013;57:219–224. doi: 10.1097/MPG.0b013e3182935474.
    1. Chan D, Robbins H, Rogers S, Clark S, Poullis A. Inflammatory bowel disease and exercise: results of a Crohn’s and Colitis UK survey. Frontline Gastroenterol. 2014;5:44–8.
    1. Taylor RW, Jones IE, Williams SM, Goulding A. Evaluation of waist circumference, waist-to-hip ratio, and the conicity index as screening tools for high trunk fat mass, as measured by dual-energy X-ray absorptiometry, in children aged 3–19 y. Am J Clin Nutr. 2000;72:490–495.
    1. WHO Multicentre Growth Reference Study Group . WHO Child growth standards: length/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development. Geneva: World Health Organization; 2006.
    1. Ravens-Sieberer U, Herdman M, Devine J, Otto C, Bullinger M, Rose M, et al. The European KIDSCREEN approach to measure quality of life and well-being in children: development, current application, and future advances. Qual Life Res. 2014;23:791–803. doi: 10.1007/s11136-013-0428-3.
    1. Frühe B, Allgaier A-K, Pietsch K, Baethmann M, Peters J, Kellnar S, et al. Children’s Depression Screener (ChilD-S): development and validation of a depression screening instrument for children in pediatric care. Child Psychiatry Hum Dev. 2012;43:137–151. doi: 10.1007/s10578-011-0254-1.
    1. IPAQ . Guidelines for data processing and analysis of the International Physical Activity Questionnaire (IPAQ) – short and long forms, revised on November 2005. 2005.
    1. Hagströmer M, Bergman P, De Bourdeaudhuij I, Ortega FB, Ruiz JR, Manios Y, et al. Concurrent validity of a modified version of the International Physical Activity Questionnaire (IPAQ-A) in European adolescents: the HELENA study. Int J Obes. 2008;32:S42–S48. doi: 10.1038/ijo.2008.182.
    1. Mathiowetz V, Wiemer DM, Federman SM. Grip and pinch strength: norms for 6-to 19-year-olds. Am J Occup Ther. 1986;40:705–711. doi: 10.5014/ajot.40.10.705.
    1. Solway S, Brooks D, Lacasse Y, Thomas S. A qualitative systematic overview of the measurement properties of functional walk tests used in the cardiorespiratory domain. Chest. 2001;119:256–270. doi: 10.1378/chest.119.1.256.
    1. Hassan J, van der Net J, Helders PJM, Prakken BJ, Takken T. Six-minute walk test in children with chronic conditions. Br J Sports Med. 2010;44:270–274. doi: 10.1136/bjsm.2008.048512.
    1. Meltzer LJ, Hiruma LS, Avis K, Montgomery-Downs H, Valentin J. Comparison of a commercial accelerometer with polysomnography and actigraphy in children and adolescents. Sleep. 2015;38:1323–30.
    1. Cohen J. Statistical power analysis for the behavioral sciences. 2. Hillsdale: N.J: Routledge; 1988.
    1. Dubinsky M. Special issues in pediatric inflammatory bowel disease. World J Gastroenterol. 2008;14:413. doi: 10.3748/wjg.14.413.
    1. Gasparetto M. Crohn’s disease and growth deficiency in children and adolescents. World J Gastroenterol. 2014;20:13219. doi: 10.3748/wjg.v20.i37.13219.
    1. Shamir R. Nutritional aspects in inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2009;48:S86–S88. doi: 10.1097/MPG.0b013e3181a15ca0.
    1. De Greef E, Hoffman I, Smets F, Van Biervliet S, Bontems P, Hauser B, et al. Paediatric Crohnʼs disease: disease activity and growth in the BELCRO cohort after 3 years follow-up. J Pediatr Gastroenterol Nutr. 2016;63:253. doi: 10.1097/MPG.0000000000001132.
    1. Kulnigg S, Teischinger L, Dejaco C, Waldhör T, Gasche C. Rapid recurrence of IBD-associated anemia and iron deficiency after intravenous iron sucrose and erythropoietin treatment. Am J Gastroenterol. 2009;12:1460–1467. doi: 10.1038/ajg.2009.114.
    1. Looker AC, Dallman PR, Carroll MD, Gunter EW, Johnson CL. Prevalence of iron deficiency in the United States. JAMA. 1997;12:973–976. doi: 10.1001/jama.1997.03540360041028.
    1. Michielan A, D’Incà R. Intestinal permeability in inflammatory bowel disease: pathogenesis, clinical evaluation, and therapy of leaky gut. Mediat Inflamm. 2015;2015:628157. doi: 10.1155/2015/628157.
    1. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys? Gut. 2006;55:426–431. doi: 10.1136/gut.2005.069476.
    1. Bernardi M, Maggioli C, Zaccherini G. Human albumin in the management of complications of liver cirrhosis. Crit Care. 2012;16:211.
    1. Birn H, Christensen EI. Renal albumin absorption in physiology and pathology. Kidney Int. 2006;69:440–449. doi: 10.1038/sj.ki.5000141.
    1. Herzer M, Denson LA, Baldassano RN, Hommel KA. Patient and parent psychosocial factors associated with health-related quality of life in pediatric inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2011;52:295–299. doi: 10.1097/MPG.0b013e3181f5714e.
    1. Rogler D, Fournier N, Pittet V, Bühr P, Heyland K, Friedt M, et al. Coping is excellent in Swiss children with inflammatory bowel disease: results from the Swiss IBD cohort study. J Crohns Colitis. 2014;8:409–420. doi: 10.1016/j.crohns.2013.10.004.
    1. Goodhand JR, Wahed M, Mawdsley JE, Farmer AD, Aziz Q, Rampton DS. Mood disorders in inflammatory bowel disease: relation to diagnosis, disease activity, perceived stress, and other factors. Inflamm Bowel Dis. 2012;18:2301–2309. doi: 10.1002/ibd.22916.
    1. Gray WN, Denson LA, Baldassano RN, Hommel KA. Disease activity, behavioral dysfunction, and health-related quality of life in adolescents with inflammatory bowel disease. Inflamm Bowel Dis. 2011;17:1581–1586. doi: 10.1002/ibd.21520.
    1. Raison CL, Capuron L, Miller AH. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 2006;27:24–31. doi: 10.1016/j.it.2005.11.006.
    1. van den Brink G, Stapersma L, El Marroun H, Henrichs J, Szigethy EM, Utens EM, et al. Effectiveness of disease-specific cognitive–behavioural therapy on depression, anxiety, quality of life and the clinical course of disease in adolescents with inflammatory bowel disease: study protocol of a multicentre randomised controlled trial (HAPPY-IBD) BMJ Open Gastroenterol. 2016;3:e000071. doi: 10.1136/bmjgast-2015-000071.
    1. Miller AH, Raison CL. The role of inflammation in depression: from evolutionary imperative to modern treatment target. Nat Rev Immunol. 2016;16:22–34. doi: 10.1038/nri.2015.5.
    1. Pittet V, Juillerat P, Mottet C, Felley C, Ballabeni P, Burnand B, et al. Cohort profile: the Swiss Inflammatory Bowel Disease Cohort Study (SIBDCS) Int J Epidemiol. 2009;38:922–931. doi: 10.1093/ije/dyn180.
    1. Walter JG, Kahn SA, Noe JD, Schurman JV, Miller SA, Greenley RN. Feeling fine: anxiety and depressive symptoms in youth with established IBD. Inflamm Bowel Dis. 2016;22:402–408. doi: 10.1097/MIB.0000000000000657.
    1. Robbins H, Poullis A, Rogers S. Inflammatory bowel disease and exercise-preliminary results of a Crohn’s and colitis UK survey. Gastroenterol Today. 2012;22:62–63.
    1. Narula N, Fedorak RN. Exercise and inflammatory bowel disease. Can J Gastroenterol. 2008;22:497–504. doi: 10.1155/2008/785953.
    1. Ng V, Millard W, Lebrun C, Howard J. Low-intensity exercise improves quality of life in patients with Crohn’s disease. Clin J Sport Med. 2007;17:384–388.
    1. Chen Y, Noble EG. Is exercise beneficial to the inflammatory bowel diseases? An implication of heat shock proteins. Med Hypotheses. 2009;72:84–86. doi: 10.1016/j.mehy.2008.06.045.
    1. Sanderson IR. Growth problems in children with IBD. Nat Rev Gastroenterol Hepatol. 2014;11:601.
    1. Colditz GA, Cannuscio CC, Frazier AL. Physical activity and reduced risk of colon cancer: implications for prevention. Cancer Causes Control. 1997;8:649–667. doi: 10.1023/A:1018458700185.
    1. Reigada LC, Hoogendoorn CJ, Walsh LC, Lai J, Szigethy E, Cohen BH, et al. Anxiety symptoms and disease severity in children and adolescents with Crohn disease. J Pediatr Gastroenterol Nutr. 2015;60:30–35. doi: 10.1097/MPG.0000000000000552.

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera